Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Legha

Showing results (81-90 of 179) with videos related to

Pageof 18
Sort By:
Blood|August 1, 1982
Evaluation of AMSA in previously treated patients with acute leukemia: results of therapy in 109 adultsS S Legha, M J Keating, K B McCredie, et al.
Journal of Indian Prosthodontic Society|July 23, 2015
Current Concepts in Restoring Acquired Cranial DefectsK V Arun Kumar, N K Singla, Mahesh E Gowda, et al.
Clinical Pharmacology and Therapeutics|September 1, 1987
Clinical pharmacology of trimetrexateD H Ho, W P Covington, S S Legha, et al.
Cancer Treatment Reports|November 1, 1979
Phase II study of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in metastatic breast cancerS S Legha, G R Blumenschein, A U Buzdar, et al.
Oncology|January 1, 1976
Neocarzinostatin (NSC 157365) a new cancerostatic compoundS S Legha, D D Von Hoff, M Rozencweig, et al.
Cancer Treatment Reports|August 1, 1980
Cytotoxic chemotherapy in adrenal cortical carcinomaM M Haq, S S Legha, N A Samaan, et al.
Cancer Treatment Reports|January 1, 1979
Rubidazone in metastatic breast cancerS S Legha, R S Benjamin, A U Buzdar, et al.
Cancer Treatment Reports|September 1, 1984
Phase I clinical investigation of homoharringtonineS S Legha, M Keating, S Picket, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Design and results of phase I cancer clinical trials: three-year experience at M.D. Anderson Cancer CenterT L Smith, J J Lee, H M Kantarjian, et al.
Cancer Treatment Reports|January 1, 1981
Zinostatin-related pulmonary toxicityD B Calvo, S S Legha, E M McKelvey, et al.
Pageof 18

Showing results (81-90 of 179) with videos related to

Sort By:
Pageof 18
Blood|August 1, 1982
Evaluation of AMSA in previously treated patients with acute leukemia: results of therapy in 109 adultsS S Legha, M J Keating, K B McCredie, et al.
Journal of Indian Prosthodontic Society|July 23, 2015
Current Concepts in Restoring Acquired Cranial DefectsK V Arun Kumar, N K Singla, Mahesh E Gowda, et al.
Clinical Pharmacology and Therapeutics|September 1, 1987
Clinical pharmacology of trimetrexateD H Ho, W P Covington, S S Legha, et al.
Cancer Treatment Reports|November 1, 1979
Phase II study of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in metastatic breast cancerS S Legha, G R Blumenschein, A U Buzdar, et al.
Oncology|January 1, 1976
Neocarzinostatin (NSC 157365) a new cancerostatic compoundS S Legha, D D Von Hoff, M Rozencweig, et al.
Cancer Treatment Reports|August 1, 1980
Cytotoxic chemotherapy in adrenal cortical carcinomaM M Haq, S S Legha, N A Samaan, et al.
Cancer Treatment Reports|January 1, 1979
Rubidazone in metastatic breast cancerS S Legha, R S Benjamin, A U Buzdar, et al.
Cancer Treatment Reports|September 1, 1984
Phase I clinical investigation of homoharringtonineS S Legha, M Keating, S Picket, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Design and results of phase I cancer clinical trials: three-year experience at M.D. Anderson Cancer CenterT L Smith, J J Lee, H M Kantarjian, et al.
Cancer Treatment Reports|January 1, 1981
Zinostatin-related pulmonary toxicityD B Calvo, S S Legha, E M McKelvey, et al.
Pageof 18